शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
MAXHEALTHNSEMAX HEALTHCARE INS LTD· Healthcare ServicesHighNegative
Announced Tue, 29 Sept, 2026 · 22:39 IST

Max Healthcare NCLT case adjourned to October 29

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.3%Reaction day
₹982.10
prior close
₹963.00
announcement price
After-mkt
timing
Nifty 100market-0.3%-5.1% vs market
Hospital peers, median of 28sector-1.8%-3.5% vs sector

On the reaction day the stock moved 5.1 pts less than Nifty 100 and 3.5 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-1.1
15m
-2.3
30m
-3.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.3-0.3-5.1-1.8-3.5
Next day
-4.2-1.2-3.0-2.3-1.9
2d
-6.6-0.6-6.0-3.9-2.7
3d
-8.1+0.4-8.4-3.4-4.6
4d
-8.0-0.4-7.6-4.9-3.0
5d
-11.1-2.2-8.8-6.2-4.8
1w
-11.8-1.6-10.3-5.4-6.4
15d
-17.0-1.4-15.6-11.6-5.4
1m
-12.4pendingpending-7.5-4.9
2m
—————
3m
—————
UpDownMarket · Nifty 100Sector · Hospital peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max Healthcare informed exchanges that the NCLT Cuttack Bench could not hear petitions filed by BRS Capital Two Pte. Limited against Kalinga Hospital Ltd (a subsidiary of Max Healthcare), another shareholder, and Max Healthcare itself on September 28, 2026 due to lack of time. The matter has been adjourned to October 29, 2026 for further hearing. The dispute relates to Max Healthcare's earlier acquisition of majority equity stake in Kalinga Hospital. No ruling or settlement has been made.

Likely market impact

Procedural delay only. No order passed against the company. Next hearing scheduled for October 29, 2026. Limited immediate impact on the stock.